Weight Loss During Intrauterine Progestin Treatment for Obesity-associated Atypical Hyperplasia and Early-Stage Cancer of The Endometrium

Intrauterine progestin is a treatment option for women with atypical hyperplasia or low-risk endometrial cancer who wish to preserve their fertility, or whose poor surgical fitness precludes safe hysterectomy. We hypothesized that in such women with obesity, weight loss during progestin treatment ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Barr, Chloe E., Ryan, Neil A.J., Derbyshire, A.E., Wan, Y. Louise, MacKintosh, Michelle L., McVey, Rhona J., Bolton, James, Fitzgerald, Cheryl, Awad, Dina, Slade, Richard J., Syed, Akheel A., Ammori, Basil J., Crosbie, Emma J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306269/
https://www.ncbi.nlm.nih.gov/pubmed/34348914
http://dx.doi.org/10.1158/1940-6207.CAPR-21-0229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306269/
https://www.ncbi.nlm.nih.gov/pubmed/34348914
http://dx.doi.org/10.1158/1940-6207.CAPR-21-0229

Ejemplares similares